{"id":"https://openalex.org/W954413508","doi":null,"title":"Ceftriaxone resistance in Neisseria gonorrhoeae: research advances.","display_name":"Ceftriaxone resistance in Neisseria gonorrhoeae: research advances.","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W954413508","mag":"954413508"},"language":"en","primary_location":{"id":"mag:954413508","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-GWYZ200904006.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764655427","display_name":"Guoji yaoxue yanjiu zazhi","issn_l":"1674-0440","issn":["1674-0440"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Guoji yaoxue yanjiu zazhi","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102034482","display_name":"Yuan LiuFeng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuan LiuFeng","raw_affiliation_strings":["Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical college, Nanjing 210042, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical college, Nanjing 210042, China","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069613785","display_name":"Yue-Ping Yin","orcid":"https://orcid.org/0000-0003-1700-2750","observed_orcids":["https://orcid.org/0000-0003-1700-2750"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yue-Ping Yin","raw_affiliation_strings":["Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical college, Nanjing 210042, China"],"raw_orcid":"https://orcid.org/0000-0003-1700-2750","affiliations":[{"raw_affiliation_string":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical college, Nanjing 210042, China","institution_ids":["https://openalex.org/I200296433"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I200296433"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"4","first_page":"264","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.8446999788284302,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.8446999788284302,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.09910000115633011,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.02250000089406967,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftriaxone-resistance","display_name":"ceftriaxone resistance","score":0.9319999814033508},{"id":"https://openalex.org/keywords/neisseria-gonorrhoeae","display_name":"Neisseria gonorrhoeae","score":1.0},{"id":"https://openalex.org/keywords/gonorrhea","display_name":"gonorrhea","score":0.7630000114440918},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.7310000061988831},{"id":"https://openalex.org/keywords/pena-gene","display_name":"penA gene","score":0.75},{"id":"https://openalex.org/keywords/mtrr-gene","display_name":"MTRR gene","score":0.9919999837875366},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.5699999928474426},{"id":"https://openalex.org/keywords/resistance-surveillance","display_name":"resistance monitoring","score":0.46000000834465027},{"id":"https://openalex.org/keywords/cephalosporin-resistance","display_name":"cephalosporin resistance","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.9750047922134399},{"id":"https://openalex.org/C2779166590","wikidata":"https://www.wikidata.org/wiki/Q131129","display_name":"Neisseria gonorrhoeae","level":2,"score":0.9696317911148071},{"id":"https://openalex.org/C2778087339","wikidata":"https://www.wikidata.org/wiki/Q18029587","display_name":"MTRR","level":5,"score":0.8869041204452515},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6142172813415527},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.556455135345459},{"id":"https://openalex.org/C2778082588","wikidata":"https://www.wikidata.org/wiki/Q101896","display_name":"Gonorrhea","level":3,"score":0.5042983293533325},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.4600541293621063},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4553861618041992},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3607942759990692},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2890815734863281},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.1951422393321991},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17289358377456665},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10464608669281006},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.07937270402908325},{"id":"https://openalex.org/C43563269","wikidata":"https://www.wikidata.org/wiki/Q424709","display_name":"Methylenetetrahydrofolate reductase","level":4,"score":0.0},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:954413508","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTotal-GWYZ200904006.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764655427","display_name":"Guoji yaoxue yanjiu zazhi","issn_l":"1674-0440","issn":["1674-0440"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Guoji yaoxue yanjiu zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2367086732","https://openalex.org/W4291676213","https://openalex.org/W2371785111","https://openalex.org/W3029916548","https://openalex.org/W4386733321","https://openalex.org/W3213779957","https://openalex.org/W3032563772","https://openalex.org/W2370862158","https://openalex.org/W2201314748","https://openalex.org/W4396675156"],"abstract_inverted_index":{"Ceftriaxone":[0],"is":[1,50],"a":[2],"first-line":[3],"drug":[4],"for":[5],"Neisseria":[6],"gonorrhoeae":[7],"treatment.In":[8],"vitro":[9],"antimicrobial":[10],"susceptibility":[11],"studies":[12,68],"have":[13],"found":[14],"few":[15,36],"N.gonorrhoeae":[16,45],"strains":[17],"resistant":[18],"to":[19,48,52,56],"ceftriaxone,though":[20],"clinical":[21],"ceftriaxone":[22,54,61],"treatment":[23],"failure":[24],"has":[25,63],"not":[26,64],"been":[27,65],"reported":[28],"worldwide.Furthermore,ceftriaxone":[29],"resistance":[30,55,62],"rates":[31],"are":[32],"above":[33],"5%":[34],"in":[35,72],"areas":[37],"of":[38,41,44,60],"China.In":[39],"view":[40],"the":[42,58,73],"tendency":[43],"less":[46],"susceptible":[47],"ceftriaxone,it":[49],"necessary":[51],"monitor":[53],"N.gonorrhoeae.Nowadays":[57],"mechanism":[59],"fully":[66],"elucidated,most":[67],"focus":[69],"on":[70],"mutations":[71],"penA":[74],"and":[75],"mtrR":[76],"genes.":[77]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}
